Birth defects after prenatal exposure to antiepileptic drugs (Q36292532)

13 August 2017

1 reference

title

Birth defects after prenatal exposure to antiepileptic drugs (English)

1 reference

13 August 2017

1

Emilio Perucca

1 reference

13 August 2017

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

11

1 reference

13 August 2017

781-786

1 reference

Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Anticonvulsant teratogenesis 5: observer bias in a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Malformations in Offspring of Women with Epilepsy: A Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Congenital malformations due to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Antiepileptic drug regimens and major congenital abnormalities in the offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

The teratogenicity of anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Major malformations in offspring of women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

The AED (antiepileptic drug) pregnancy registry: a 6-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Lamotrigine and the risk of malformations in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Increased rate of major malformations in offspring exposed to valproate during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Antiepileptic drug use of women with epilepsy and congenital malformations in offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Malformation rates in children of women with untreated epilepsy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Teratogenicity of antiepileptic drugs: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Teratogenicity of sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Oxcarbazepine in pregnancy: clinical experience in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Safety of the newer antiepileptic drug oxcarbazepine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Common antiepileptic drugs in pregnancy in women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Additional educational needs in children born to mothers with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Normal intelligence in children with prenatal exposure to carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Neuropsychological effects of exposure to anticonvulsant medication in utero

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

The Use of Folic Acid for the Prevention of Neural Tube Defects and Other Congenital Anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

Management issues for women with epilepsy: neural tube defects and folic acid supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970224-6

7 January 2021

10.1016/S1474-4422(05)70224-6

Identifiers

DOI

1 reference

release_3bnf4ts2wfct3fi6ykv4ohcvpu

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3bnf4ts2wfct3fi6ykv4ohcvpu

24 November 2022

mapped directly with Wikidata item

PubMed ID

16239185

1 reference

PubMed ID

16239185